![MRSA Enterococcus Clostridium difficile EbolavirusMERS
The Human and Financial Costs of Hospital Infections
Infections contracted in hospitals are the fourth largest killer in America. Every year
in this country, two million patients contract infections in hospitals, and an estimated
103,000 patients die as a result, equaling the number of deaths each year from AIDS,
breast cancer and auto accidents combined.
BETSY MCCAUGHEY, PH.D.
FOUNDER AND CHAIRMAN, THE COMMITTEE TO
REDUCE INFECTION DEATHS (hospitalinfection.org)
[1] Robert Weinstein, “Nosocomial Infection Update,” Emerging Infectious Diseases 4.3 (1998)
[2] Interview with Nicole Coffin, spokes-person for the CDC, Infectious Diseases Division, October 10, 2002 (404-639-2888).
SPECTRA254 HAS A PORTFOLIO OF
ADVANCED UVC PRODUCTS THAT HAS BEEN
INDEPENDENTLY CERTIFIED TO REDUCE OR
ELIMINATE 99.98% OF ALL PATHOGENS.](https://image.slidesharecdn.com/3ab4b43b-9ae5-4fd4-ba6e-5f840d302cdc-160318133828/85/Spectra254-Corp-Brochure-3-320.jpg)
Spectra254-Corp-Brochure
- 1. Advancing UVC Technology for Better Health The Practical Approach to Better Infection Control spectra254.com
- 2. Healthcare Acquired Infections (HAIs) are a multi- million dollar problem in today’s healthcare field. According to the CDC (Centers for Disease Control and Prevention), new antibiotic-resistant bacteria are becoming more prevalent everyday. With the diversity of diseases occurring in hospitals and the pathogens that can cause them, it is not hard to understand how if left unchecked, these diseases can spread to other patients, visitors and employees. Hospitals, assisted living facilities, senior care facilities, and sports and recreation facilities are all prime targets for the spread of these conventional- treatment resistant pathogens. Reduction in HAIs According to the CDC, hospitals spend more than $40 billion annually treating in-hospital infections. Yet housekeepers typically can only clean about 50% of the surfaces that need cleaning. The national average of direct costs to a hospital for treating HAIs is $20,000 per infection. The prevention of only two infections per year will more than recoup the entire cost of a Spectra254 solution? and the ongoing impact of reduced HAIs has the potential to save your facility millions of dollars. C. diff, MRSA, salmonella and other superbugs pose significant danger within hospitals and healthcare related facilities, impacting 600,000 individuals a year, according to the CDC, or one in every 25 hospital patients. The Unrealized Costs of HAIs Poor quality of care and patient experiences affect reimbursements. Medicare may penalize your facility for deficient scores. For example, a 300-bed hospital with poor infection prevention metrics can be penalized approximately $1.3 million a year. Litigation is a reality faced by health care facilities on a daily basis. If a patient contracts an infection while being treated for an unrelated medical condition, this can expose the hospital to additional liabilities. When you use Spectra254 products, you are taking proactive measures to reinforce your facilities’ dedication to eliminating preventable healthcare challenges. You not only reduce human error possibility intrinsic with manual cleaning, but you may also reduce the chance of being harmed by litigation. The Real Cost of HAIs
- 3. MRSA Enterococcus Clostridium difficile EbolavirusMERS The Human and Financial Costs of Hospital Infections Infections contracted in hospitals are the fourth largest killer in America. Every year in this country, two million patients contract infections in hospitals, and an estimated 103,000 patients die as a result, equaling the number of deaths each year from AIDS, breast cancer and auto accidents combined. BETSY MCCAUGHEY, PH.D. FOUNDER AND CHAIRMAN, THE COMMITTEE TO REDUCE INFECTION DEATHS (hospitalinfection.org) [1] Robert Weinstein, “Nosocomial Infection Update,” Emerging Infectious Diseases 4.3 (1998) [2] Interview with Nicole Coffin, spokes-person for the CDC, Infectious Diseases Division, October 10, 2002 (404-639-2888). SPECTRA254 HAS A PORTFOLIO OF ADVANCED UVC PRODUCTS THAT HAS BEEN INDEPENDENTLY CERTIFIED TO REDUCE OR ELIMINATE 99.98% OF ALL PATHOGENS.
- 4. Patient Safety Requires It “Efficacy” Ξ Spectra254 systems offer the highest UVC dosage available – up to 300,000 mW per centimeter squared. Independent studies confirm our ability to kill C. diff spores to a level of efficacy greater than 99.9% Ξ Spectra254 products can decontaminate a 400 square foot space in five minutes. “Reliability” Ξ All Spectra254 products include an all-inclusive three–year, no additional cost total warranty. Ξ Spectra254 UVC lamps have a lifespan of more than 10,000 hours. “Ease of Use” Ξ All systems include internal safety controls and a front panel display Ξ Spectra254 systems are available with three control options. • Handheld Remote Control • Tablet Control for Data Collection • Tablet Control for Data Collection with Bar-Code Reader. “Turnaround Time” Ξ Thorough room decontamination is critical to patient safety. Room turnover is critical to the bottom line. Spectra254 systems can decontaminate a room in five minutes, and a typical sized patient room can be readied for the next patient in 15 minutes or less. “Total Cost of Ownership” Ξ Spectra254 offers a comprehensive systems approach to infection control with a product line targeted for every application. Because the competitive acquisition cost of each product includes all service and maintenance and an all-inclusive three-year warranty, Spectra254 products offer the lowest total cost of ownership.
- 5. Independently Tested & Verified* Ξ C. diff Spores Reduction = 99.98% (3.6 Log10) 5 Minutes at 5 Feet Ξ MRSA Reduction = 99.996% (4.34 Log10) 5 Minutes at 5 Feet Ξ Ebola (surrogate) Reduction = 99.99% (4.05 Log10) 5 Minutes at 5 Feet Ξ Human Enterovirus Reduction = 99.99% (4.0 Log10) 5 Minutes at 5 Feet Ξ MERS Reduction = 99.96% (100% Reduction) 5 Minutes at 5 Feet Ξ Aerosol Study > 99.998% (4.77 Log10) Reduction 15 Minutes * Spectra 1000 Reports, Antimicrobial Test Laboratories Independent Tests Confirm It The Studies Prove It All Spectra254 test reports are published on our website for you to review. Scan the QR Code to view the available reports, or visit: www.spectra254.com/product-literature/ Why Spectra254? Ξ Spectra254 offers the widest range of products designed to solve infection control problems in all types of facilities from the smallest to the largest. Ξ Spectra254 products are proven to offer better performance and are the most cost-effective solution available today. Ξ Spectra254 systems are made in the United States and Spectra254 is the only company that offers maintenance and a three-year full warranty at no additional charge.
- 6. The Most Complete Line of UVC Decontamination Products Available in different models with different sizes, power options and features, Spectra254 offers a system for every application. Applications Ξ Hospitals and Healthcare Facilities Ξ Hotels and Hospitality Facilities Ξ Detention Facilities Ξ Food Preparation and Processing Ξ Pharmaceutical Manufacturing Ξ Athletic and Training Facilities Eliminates all Guesswork In a 100 square foot room with the unit placed in the center of the room, the Spectra 1000 Series delivers 33 times the energy needed to eliminate 99.9% of the MRSA pathogen and C. diff spores in only five minutes. SPECTRA Data Capture Available on the Spectra 1000, 1100, and 600 models The Spectra254 Tablet is for system operation and data collection. Logs: Date – Time – Room Number – User ID – Treatment Time – Results Spectra254 Bar Code Reader will capture the User ID and Room Number. The data is then stored in Excel format and can be downloaded to a USB memory stick, or can be transferred to another device via Wi-Fi connection. Acute Care Athletic Emergency Vehicles Medical Tools Hospitality Pre/Post-Acute Care Spectra254 Tablet Interface
- 7. SPECTRA 1000 SERIES Ξ Designed for use in Hospitals (“OR”), Laboratories & Professional Sports Facilities Ξ The Best of the Best. Cleans the entire room, decontaminating surfaces and the air SPECTRA 1100 SERIES Ξ Designed for use in Ambulatory Care & Nurse Assisted Living Facilities Ξ Portable, easily moved in standard corridors SPECTRA 600A Ξ Designed for use in Clinics & Post-Acute Care Health Facilities Ξ Cost-effective UVC solution for doctors’ offices, clinics, and examination rooms SPECTRA 500 SERIES Ξ Designed for use in Ambulances & Medical Transports Ξ Compact and lightweight for small areas with low clearance RDS-30 AND RDS-32 Ξ Designed for countertop use in Medical Facilities & Laboratories Ξ Decontaminates objects such as TV remote controls, cell phones, and tablets Setting the Standard for Safe & Effective Use Mobile UVC Decontamination Systems Available Now Countertop UVC Decontamination Systems Available Now
- 8. 2 Oct 2015© 2015 Spectra254, LLC. All Rights Reserved. “Spectra254,” and the “Spectra254 Logo” are registered trademarks of Spectra254, LLC. 21 Commerce Drive Danbury, CT USA Toll-Free: 1-844-773-2875 Telephone: 1-203-796-5315 Fax: 1-203-796-5319 spectra254.com Support Spectra254 provides complete U.S.-based support for all Spectra254 models. Our Customer Care team is available Monday-Friday, 8am – 5pm, to handle questions and support. All Spectra254 disinfection products are easy to operate. Complete operation instructions are included and available at Spectra254.com. Our Tech Support Team is available to help with any challenges you may encounter. Telephone 1-203-796-5315 Toll-Free 1-844-773-2875 The Company Spectra254, located in Danbury, Connecticut, specializes in decontamination systems for use in applications throughout the world. Spectra254 systems are made in the United States using the highest-quality components. The Danbury facility is home to all engineering, manufacturing, customer support and operation. To learn more about the Spectra254 line of decontamination systems, please visit www.spectra254.com